Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 02, 2022

SELL
$9.81 - $15.4 $101,072 - $158,666
-10,303 Closed
0 $0
Q4 2021

Feb 07, 2022

SELL
$12.09 - $14.68 $4,908 - $5,960
-406 Reduced 3.79%
10,303 $139,000
Q3 2021

Nov 09, 2021

SELL
$13.25 - $15.13 $7,658 - $8,745
-578 Reduced 5.12%
10,709 $145,000
Q2 2021

Aug 03, 2021

SELL
$12.97 - $16.15 $168,259 - $209,513
-12,973 Reduced 53.47%
11,287 $161,000
Q1 2021

Apr 28, 2021

SELL
$13.59 - $18.54 $12,611 - $17,205
-928 Reduced 3.68%
24,260 $339,000
Q4 2020

Feb 08, 2021

BUY
$14.3 - $18.74 $360,188 - $472,023
25,188 New
25,188 $472,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Parsons Capital Management Inc Portfolio

Follow Parsons Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parsons Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Parsons Capital Management Inc with notifications on news.